Abstract:Background: The prognosis of hepatocellular carcinoma (HCC) is closely associated with recurrence and metastasis which has been proposed to be initiated by circulating tumor cells (CTCs). Yet, the transcriptomic plasticity and immune evasion mechanism of CTCs during circulation are not well defined. Methods: Blood was drawn from 4 different vascular sites, including hepatic vein (HV), peripheral artery (PA), peripheral vein (PV) and portal vein (PoV) of 10 localized HCC patients. Single CTCs were isolated by negative enrichment and robotic micromanipulator, followed by single-cell RNA sequencing (scRNA-seq). After filtering, 113 CTCs with qualified data were subjected to bioinformatics analysis. The scRNA-seq results were further validated in three independent HCC cohorts. Results: Our scRNA-seq data revealed remarkable intra- and inter-vascular heterogeneity among CTCs from four vascular sites. We determined CTC transcriptional dynamics during transportation through consecutive vascular sites and revealed their adaptation mechanisms under biomechanical stress. We further classified CTCs from different vascular sites into two subsets, namely dormant and activated CTCs. Dormant CTCs were associated with a non-cycling state and upregulation of EMT/angiogenic signatures and showed stronger prognostic ability for early relapse than activated CTCs. Furthermore, we discovered an immune escape mechanism by which CTCs recruited regulatory T cells (Tregs) via expression of CCL5, consequently promoting the formation of an immunosuppressive microenvironment favorable for their survival in bloodstream and distant colonization.We proved that MAX, activated through the p38 pathway, was the key transcriptional factor regulating CCL5 overexpression, which was validated by ChIP, luciferase reporter gene and in vitro/vivo knockdown assays. And we further determined that Tregs-derived TGF-β1 can heighten MAX expression, thus amplifying the CCL5 expression. Conclusions: Collectively, our results reveal a previously unappreciated spatial heterogeneity of CTCs and a CTC immune-escape mechanism, which may aid in designing new anti-metastasis therapeutic strategies in HCC. Legal entity responsible for the study: Jia Fan. Funding: The State Key Program of National Natural Science of China. Disclosure: All authors have declared no conflicts of interest.

Single-cell RNA Sequencing Reveals Spatial Heterogeneity and Immune Evasion of Circulating Tumor Cells

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

Abstract 4601: Dissecting the Spatial Heterogeneity of Circulating Tumor Cells Reveals CCL5-Treg-mediated Immune Evasion in Hepatocellular Carcinoma

Dissecting the Spatial Heterogeneity of Single Circulating Tumor Cells Reveals Immune Evasion Through MAX Regulated CCL5 Overexpression in Hepatocellular Carcinoma.

Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

Data from Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma

Circulating Tumor Cells: Biological Features and Survival Mechanisms

Dissecting the Spatial Heterogeneity of Single CTCs Reveals Immune Evasion Through MAX Regulated CCL5 Overexpression in Hepatocellular Carcinoma

Single-cell Analyses of Circulating Tumor Cells

Molecular Characterization of Circulating Tumor Cells-from Bench to Bedside

Circulating tumor cells: biology and clinical significance

Enrichment and Single-Cell Analysis of Circulating Tumor Cells.

A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

Unravelling the Heterogeneity and Dynamic Relationships of Tumor-Infiltrating T Cells by Single-Cell RNA Sequencing Analysis

Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer

Detection of Mrnas of Ribosomal Protein L15 and E-Cadherin in Living Circulating Tumor Cells at Single Cell Resolution to Study Tumor Heterogeneity.

Using single-cell sequencing technology to detect circulating tumor cells in solid tumors

Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer

Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis